Why Insmed Incorporated (INSM) Stock Fell 6.6% on Oct 5, 2026
The clearest new catalyst: CFO resignation announcement.
Why did INSM stock fall?
Insmed shares declined 6.6% on October 5, 2026, following the company's announcement that CFO Sara Bonstein will resign effective October 30, 2026, after nearly seven years in the role. Although Insmed reaffirmed its full-year 2026 financial guidance and Bonstein will remain through the end of October to support Q3 reporting and the October 29 earnings call, the leadership transition prompted the selloff.
- CFO resignation announcement: Sara Bonstein announced her departure as CFO effective October 30, 2026, after nearly seven years in the position. She will remain through end-October to support Q3 reporting and the earnings call.
- Full-year 2026 guidance reaffirmed: Despite the CFO transition, Insmed reaffirmed its full-year 2026 financial guidance, providing some reassurance on near-term business momentum.
Initial detection
BestStocks first flagged INSM intraday on Oct 5, 2026; this analysis was finalized after the close using the confirmed −6.6% session move and additional catalyst research.
Show the initial intraday note
Insmed announced CFO Sara Bonstein's resignation effective October 30, 2026, after nearly seven years in the role (investor.insmed.com). Despite reaffirmed full-year 2026 guidance, the stock declined 4.64% to $105.96 intraday. Bonstein will remain through end-October to support Q3 reporting and the earnings call scheduled for October 29.
What to watch next: Q3 2026 earnings call on October 29, 2026; announcement of CFO successor and any updates to full-year 2026 guidance.
Other developments that session
Insmed Announces CFO Transition
INSM filed a new 8-K on 2026-10-05.
Frequently asked questions
Why did Insmed Incorporated (INSM) stock fall on Oct 5, 2026?
Insmed shares declined 6.6% on October 5, 2026, following the company's announcement that CFO Sara Bonstein will resign effective October 30, 2026, after nearly seven years in the role. Although Insmed reaffirmed its full-year 2026 financial guidance and Bonstein will remain through the end of October to support Q3 reporting and the October 29 earnings call, the leadership transition prompted the selloff.
How much did INSM stock fall on Oct 5, 2026?
INSM fell 6.6% during the Oct 5, 2026 trading session.
What were the main drivers behind INSM's move?
CFO resignation announcement; Full-year 2026 guidance reaffirmed.